Here are some of the equities that saw shifts in price targets and/or ratings on Friday.
Equity Name |
Symbol |
Delta In Change |
Key Comments From The Note |
Firm |
Zebra Technologies |
ZBRA |
-9.41% |
Potential Earnings Acceleration From Deleveraging.
Maintaining Our In-Line Rating And Lowering Our Price Target To $77 From $85 |
Imperial Capital |
Medifast Inc |
MED |
-5.88% |
Revenue Disappoints; Eps Beats On Lower Spending |
Imperial Capital |
Masonite International Corporation |
DOOR |
3.17% |
3q14 Results Reflect Continued Leverage To Housing Recovery And Domestic Door Pricing; Maintaining Our Outperform Rating, And Raising Our Price Target From $63 To $65 |
Imperial Capital |
Zynga Inc. |
ZNGA |
0.58% |
We Maintain Our Underperform Rating And Our Target Price Is Now $3.44 (vs. $3.42 Prior). Our Fy14 And Fy15 Adj. Eps Estimates Are Now $0.00 And $0.06 Respectively. |
Credit Suisse |
First Solar Inc. |
FSLR |
|
Although Management Lowered Its Cy14 Revenue Guidance Range Slightly, It Maintained Eps Guidance (ex-tax Benefit) Primarily Due To Strong 3q14 Gross Margin. We Maintain Our Underperform Rating And Our Estimates Trend Lower. |
Bank Of America |
Ubiquiti Networks |
UBNT |
-25.00% |
Troubled Near-Term Climate Does Not Trump Ubiquiti’s Longer-Term Opportunities In Our View.
We Maintain Our Buy Rating But Lower Our Ptto $45, Reflecting A 19x P/E Multiple For Fy16. |
Bank Of America |
Ubiquiti Networks |
UBNT |
|
We Remain Positive On Ubnt's Thesis Of Entering Underserved Markets With Price Disruptive Products, But At 14x Fy16e Eps, We Think The Company Is Fairly Valued. |
Morgan Stanley
|
Medivation, Inc. |
MDVN |
12.38% |
Medivation Now Guided Its Full Year Guidance For Xtandi Us Sales To Be At The High End Or Just Above The Previous Guidance Of $600-640 Million.
We Raise Our Tp To $118 From $105, Reflecting Increased Revenue Projections.. |
|
Soufun Holdings Ltd. |
SFUN |
-20.00% |
We Are Fundamentally Positive Longer Term On Sfun’s Strategy To Leverage Its Online Traffic To Engage More Closely In A Transaction (ex. Capture Higher Commissions From Developers In Property Sales And Fees In Financial Services)
Lower Pt From $15 To $12 |
Brean Capital |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.